Current Clinical Trials

NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-Refractory Patients With Non-Muscle Invasive Bladder Cancer

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy - Completed

Hexvix Cystoscopy for Detection of Bladder Cancer

Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide - Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Detection of Bladder Cancer Microsatellite Analysis (MSA) of Urinary Sediment - Closed

Survivin Urine mRNA Assay Risk of Bladder Cancer Study - Completed

Please log-in or register in order to submit comments.

Powered by AkoComment!